A Phase 1, Open-label, Randomized, 2-period Crossover Drug Interaction Study in Healthy Adult Subjects to Evaluate the Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of SSP-002358.

Trial Profile

A Phase 1, Open-label, Randomized, 2-period Crossover Drug Interaction Study in Healthy Adult Subjects to Evaluate the Effect of the Proton Pump Inhibitor Omeprazole on the Pharmacokinetics of SSP-002358.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2014

At a glance

  • Drugs SPD 557 (Primary) ; Omeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 29 Sep 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
    • 29 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top